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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S154Figure 3. Histology (Safranin O staining) of one unique SH clot sample
showing matrix formation surrounding cells (red stain) with evidence of
lacunae formation after 2 weeks in vivo.
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CARTILAGE TISSUE ENGINEERING: ADULT HUMAN MESENCHYMAL
STROMAL CELLS AND COLLAGEN BIOMATERIALS
C. Sanjurjo-Rodríguez y,z, A.H. Martínez Sanchez y,
T. Hermida-Gomez y, I.M. Fuentes y,z, J. Bujan x, F.J. De Toro z,
S. Díaz-Prado y,z, F.J. Blanco; y. y INIBIC- Univ. Hosp. of A Coru~na (CHUAC),
A Coru~na, Spain; z INIBIC Dept. of Med., Univ. of A Coru~na, A Coru~na, Spain;
xDept. of Med. Specialties, Univ. of Alcala de Henares, Madrid, Spain
Purpose: The purpose was to study chondrogenesis of adult human
Mesenchymal Stromal Cells, isolated from bone marrow (hBMSCs),
when culture on collagen (Col) biomaterials and to evaluate the suit-
ability of the neotissue formed to use in Tissue Engineering.
Methods: hBMSCswere culturedduring30days inchondrogenicmedium
with Transforming growth factor b-3 (TGFb-3) on the following bio-
materials: Col I, Col IþCol II, Col Iþ heparan sulphate (HS), Col IþCol IIþ
heparan sulphate (HS), Col IþCol IIþ chondroitin sulphate (CHS) and Col
Iþ heparin (OLH3).
We have tested growth and cell morphology on the constructs by histo-
chemical and Scanning (SEM) and Transmission (TEM) Electron Micro-
scopy. Chondrogenic differentiationwas evaluated in all the constructs by
histochemical and immunohistochemistry analyses and molecular biol-
ogy.Moreover, Col concentrationwasmeasured in supernatants along the
culture.
Results: Histology showed that hBMSCs have grown through the scaf-
folds, being the cell percentage respect to the total area of the scaffold:
>75% in Col I, Col IþCol II, Col IþHS, Col IþCol IIþHS, Col IþCol IIþCHS;<
50% in Col IþOLH3. It was observed a big amount of extracellular matrix
(ECM), except in Col IþOLH3. ECM from Col IþCol II and Col IþHS showed
the higher metachromasia for Safranin O proteoglycan staining, whereas
Col I, Col IþCol IIþHS, Col IþCol IIþCHS showed an intermediate meta-
chromasia (Figure). Col II immunostainingwas highly positive in Col I and
Col IþHS ECM and positive intracellularly in Col IþCol II, Col IþCol IIþ HS,
Col IþCol IIþCHS (Figure). Col IþOLH3 did not show positivity for pro-
teoglycans and Col II. By measurement of relative expression levels (REL),
COL II gene expression was seen in cells all over the biomaterials, Col I
(0.63 REL), Col IþCol II (1.00 REL), Col IþHS (0.47 REL), Col IþCol IIþHS
(0.93 REL), Col IþCol IIþCHS (3.57 REL) and Col IþOLH3 (5.20 REL). AGG
gene expressionwas higher in Col IþCol IIþHS (6.47 REL) constructs than
in Col I (0.00 REL), Col IþCol II (0.95 REL),Col IþHS (0.17 REL), Col IþCol
IIþCHS (0.00 REL) and Col IþOLH3 (0.00 REL). TEM analysis showed a bigamount of mitochondria and oval/rounded shape cells (Figure). We could
also see oval/rounded cells and ECM by SEM.
Col released (measured as mg/total volume) was detected in all the
supernatants, ﬁnding the highest concentration in Col IþHS biomaterials
cultures except at day 21: Col I (137.33), Col IþCol II (0.00), Col IþHS (0.00),
Col IþCol IIþHS (3.33), Col IþCol IIþCHS (13.90) and Col IþOLH3 (0.00).
Conclusions: Data showed hBMSCs are able to attach and proliferate on
all Col biomaterials, except in Col IþOLH3. These cells showed abundant
ECM. Analysis showed differentiated cellular phenotype and an ECM
similar to cartilage, inbiomaterials composedbyHS. Theneotissue formed
in the other biomaterials showed an intermediate phenotype. The neo-
tissue formed in Col and HS biomaterials could be useful for cartilage
tissue engineering. Acknowledgements: B. Parma (OPOCRIN S.P.A.); CAM
(S2009/MAT-1472); CIBER BBN CB06-01-0040; Red Gallega de Terapia
Celular (REDICENT); SAI-UDC; CSR is beneﬁciary of a fellowship from
Diputacion de A Coru~na; P. Esbrit (Fundacion Jimenez Díaz).
Figure: Images from the different constructs (columns). Ordered in rows
are shown the different analysis: Scanning (SEM) and Transmission (TEM)
Electron Microscopy, Safranin O staining (SO) and Collagen type II
immunostaining (Col II).
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MRI MORPHOLOGICAL AND QUANTITATIVE EVALUATION OF KNEE
ALLOGRAFT REPAIR AT 3, 6 AND 9 MONTHS POST-OP: EARLY
SURVEILLANCE DEMONSTRATES NASCENT PHYSIOLOGICAL
INCORPORATION OF ALLOGRAFT MATERIAL IN PAIN FREE PATIENTS
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K. Baum k. yQmetrics, Cincinnati, OH, USA; zCommonwealth Orthopaedic
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Purpose: 1) Morphologically and quantitatively characterize the
appearance and incorporation of allograft material in patients who
are status-post knee articular cartilage (AC) allograft repair; 2) Compare
the characterizations in patients who are pain free with those who
are not.
Methods: Patients undergoing knee AC allograft (Biocartilage) procedures
at our institution receive follow-up MRIs Q three months. All patients are
scanned at 1.5 T (:450W, GE) with a dedicated 8 channel knee coil. Mor-
phological sequences include sagittal 2D PD FSFSE, 3D PD FS FSE and
coronal FSEIR.Quantitative sequences includemulti-echoand two-echoT2
Mapping. In addition, the 3D PD FS FSE sequences are segmented (Qme-
trics), and 3D thickness maps are rendered from the segmented data sets.
The morphological images are assessed for allograft ﬁll, bony edema,
osteophyte formationand the stabilityand integrityof theadjacentAC.The
quantitative data sets are evaluated to assess the degree on allograft
incorporation, speciﬁcally to determine the extent to which the allograft
material has T2 and thickness map values similar or not to the native
cartilage. These results are then correlated with each patient’s pain score
and function. Thus far, eightpatients havehadninemonth follow-upMRIs.
Results: Thus far, all patients’ allografts (N ¼ 8) show good ﬁll morpho-
logically at 3 months; the T2 Map values of the allografts at 3 months all
have higher values relative to the native cartilage - even if the adjacent
native cartilage is diseased - which indicates lower collagen and matrix
organization. At three months, the thickness maps demonstrate good
allograft ﬁll. All patients thus far studied have improved pain scores and
function relative to their pre-operative status. At 6 months, the morpho-
logical and thickness map data show improved allograft ﬁll, with
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patients indicate mild shortening of the values, especially at the scaf-
folding edges and the deepest layers, which suggests early organization of
the allograft. Thus far, no patient studied at 6 months has worsening pain
or clinical scores relative to the pre-operative and 3month time points. At
the 9 month time point, seven patients (N ¼ 7) have stable or improved
morphological and thickness map data, as well as further decreasing T2
values; the zones of T2 shortening in these patients have broadened. One
patient (N ¼ 1) at nine months has slight thinning of the allograft ﬁll
morphologically and on the segmented thickness maps; this patient’s T2
values are stable (Fig 1). All patients at nine months have either stable or
improved pain and function scores.
Conclusion: Initial results indicate that MRI morphological and quanti-
tative data can be used to monitor patients who are post-allograft repair.
Obviously,more longitudinal data are needed to verify the utility ofMRI as
a biomarker for allograft repair success or failure. Future work also will
include fusing thickness map and T2 data, so as to display optimally
quantitative data, in intuitive, clinically useful renderings (Fig. 2).Fig 1. Tosp left image is a sagittal image of a patient with a large, discrete
AC defect of the medial femoral condyle. The top right image is of the
same patient six months post allograft repair; the image shows good
allograft material ﬁll in the prior defect. The bottom image is a multi-echo
T2 Map of the same patient six months post allograft repair. The T2 Map,
acquired during the same six month scanning session demonstrates early
AC incorporation and organization.
Fig 2. T2 data is fused to 3D thickness map derived from automated
segmentation to generate a 3D T2 Map. Courtesy: Jose Tamez-Pena254
IN SITU EVALUATION OF CHONDROFIX OSTEOCHONDRAL
ALLOGRAFT 25 MONTHS FOLLOWING IMPLANTATION: A CASE
REPORT
K.L. Reynolds y, S.K. Bishai z. yHenry Ford Hlth.Systems, Detroit, MI, USA;
zAssociated Orthopaedics of Detroit, Detroit, MI, USA
Introduction: Surgical management of large, full-thickness osteo-
chondral defects of the knee in young to middle-aged patients poses
a difﬁcult problem for orthopaedic surgeons. Full-thickness articular
cartilage defects are common in young active patients, many of
which do not have underlying alignment issues. Without inter-
vention, these osteochondral lesions will continue to cause pain
indeﬁnitely, and typically progress to global joint degeneration due
to the limited intrinsic healing capacity of cartilage. Fresh osteo-
chondral allograft transplantation is a suitable treatment option for
these larger chondral defects, especially transplantation of fresh
osteochondral allografts. Although fresh osteochondral allograft
transplantation has become an increasingly popular technique for
osteochondral repair, donor site morbidity and unpredictable obsta-
cles can create longer wait times for patients undergoing
transplantation.
An alternative allograft has been developed, addressing the current
drawbacks associated with fresh osteochondral allograft usage.
Chondroﬁx Osteochondral Allograft (Zimmer, Austin, USA) is a de-
cellularized, osteochondral graft of hyaline cartilage and cancellous
bone. Chondroﬁx has been terminally sterilized and virus-inacti-
vated with low dose gamma irradiation (15 -18 kGy) at low temper-
atures (below 0C). Further processing includes chemical lipid
extraction of the allograft in an effort to decrease incorporation time.
Chondroﬁx is currently being used to resurface osteochondral
lesions in the knee, however, to our knowledge, there are no reports
providing gross in situ examination of the osteochondral allograft
following implantation. This article reports a unique situation in
which a Chondroﬁx allograft plug is inserted and subsequently
arthroscopically evaluated at 18 and 25months post-implantation in a
patient undergoing concomitant ACL reconstruction and medial
meniscal allograft transplantation.
Case report: At the time of injury, the patient was a 16-year-old com-
petitive soccer player who suffered an ACL rupture as well as a large
medial femoral condyle OCD (1.6 cm x 1.5 cm) and concomitant medial
meniscal tear during play. He was initially treated with an allograft
hamstring ACL reconstruction and Chondroﬁx osteochondral allograft
implantation as well as medial meniscectomy. However, at 18 months
postoperatively, he re-ruptured his ACL and suffered further tearing of
his medial meniscus requiring revision ACL reconstruction and menis-
cal allograft transplantation. The Chondroﬁx allograft was evaluated
at this time and found to be healed and rigidly incorporated in the host
condyle. Minimal demarcation, with smooth borders and appropriate
contour could be seen between the chondral surface of the host and the
allograft. Additionally, little to no wear was noted on the opposing
cartilage surface. After return to sport 25 months post implantation of
the Chondroﬁx allograft, the patient, again, re-ruptured his ACL
requiring a staged revision reconstruction. Again, the allograft plug was
evaluated. At over two years since placement, gross examination
revealed difﬁculty in identifying distinct borders. Further, probing of
the articular allograft cartilage was consistent with the patients’ native
tissue.
Discussion: Our unique case report demonstrates a rare second and
subsequently third look 25 months after initial implantation of a
Chondroﬁx graft in a young athlete. Upon examination, the graft
demonstrated complete bony incorporation with undetected articu-
lar cartilage margins, and restoration of native femoral condylar
radius of curvature. These results were found despite an extremely
suboptimal healing environment; the patient underwent multiple
operations, he had a signiﬁcant meniscal tear eventually requiring
allograft transplantation, and he was, at times, devoid of an ACL for
many months.
Full-thickness osteochondral defects in young patients can be managed
surgically, and Chondroﬁx provides an additional option for the
treatment of these lesions in the knee.
